AUCKLAND, New Zealand--(BUSINESS WIRE)--Aug. 1, 2006--GeneDetect (Bradenton, Florida and Auckland, New Zealand), a leading supplier of products and services to academic and government research institutions as well as pharmaceutical and biotechnology companies, announced today that it plans to divest its branded GeneDetect(R) and GreenStar hyperlabeled gene probe product ranges to allow the company to pursue alternative strategic opportunities. The company expects the deal to be completed early 2007.
